We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance

Results: 1-10 of 1,416

Patent claims for ‘personalised medicines’
  • Mewburn Ellis LLP
  • European Union, USA
  • February 7 2013

As previously reported the US Supreme Court, in Mayo v. Prometheus, recently invalidated Prometheus's diagnostic claims - directed to a method of

EU political update: 17 - 21 March 2014
  • Clifford Chance LLP
  • European Union, USA
  • March 17 2014

On 13 March 2014, the European Parliament voted in favour of the Network and Information Security ('NIS') Directive. The intention of the Directive is

Unlocking the Promise of Personalized Medicine: Reimbursement, Coverage, and Clinical Utility
  • Foley & Lardner LLP
  • European Union, USA
  • September 15 2014

AmerisourceBergen, in connection with the Business of Personalized Medicine Summit, released "Unlocking the Promise of Personalized Medicine:

European markets less than enthusiastic over biosimilars
  • Shook Hardy & Bacon LLP
  • European Union, USA
  • December 12 2013

While Europe has had a regulatory approval pathway for biosimilar drug products for some years, their use reportedly remains anemic. Physicians are

Employment law commentary, August 2015
  • Morrison & Foerster LLP
  • European Union, USA
  • August 28 2015

The extent of an employer’s duty to provide reasonable accommodations to employees with mental impairments can be difficult to discern, especially

Digital health law update Vol. 1 Issue 5
  • Jones Day
  • European Union, USA
  • October 6 2015

The Office of National Coordinator for Health Information Technology ("ONC") recently released a white paper, titled Designing the Consumer-Centered

Cyber security rules ‘under observation’
  • Freshfields Bruckhaus Deringer LLP
  • Asia-Pacific, European Union, USA
  • May 18 2015

A study released in May 2015 of 90 covered healthcare organisations under the US Health Insurance Portability and Accountability Act

Technology outpacing regulation
  • Freshfields Bruckhaus Deringer LLP
  • China, European Union, USA
  • May 18 2015

Healthcare services and products are highly regulated throughout their life cycle - from product development to market entry, distribution and

Food, dietary supplement & cosmetics regulatory update volume II, issue 13
  • Jones Day
  • Canada, European Union, USA
  • June 24 2015

Last week, FDA finalized its determination that partially hydrogenated oils ("PHOs") are not "generally recognized as safe" ("GRAS") for use in human

No more Safe Harbor: what should life sciences and biotech companies be doing to transfer data to the US?
  • Cooley LLP
  • European Union, USA
  • October 13 2015

Last week Europe's highest court, the Court of Justice of the European Union (CJEEA) declared the Safe Harbor Framework invalid. Many life sciences